Log in
Enquire now
‌

US Patent 8790647 Treatment of vasculoproliferative conditions with Lrg1 anatgonists

Patent 8790647 was granted and assigned to UCL Business Ltd on July, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
UCL Business Ltd
UCL Business Ltd
Date Filed
September 6, 2010
Date of Patent
July 29, 2014
Patent Application Number
13393531
Patent Citations Received
‌
US Patent 12071476 IL-6 antibodies and fusion constructs and conjugates thereof
0
‌
US Patent 11686731 Prostate cancer markers and uses thereof
0
‌
US Patent 11692840 Device, method, and graphical user interface for synchronizing two or more displays
0
‌
US Patent 11912784 Methods of treating an eye disorder
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8790647
Patent Primary Examiner
‌
Christine J. Saoud

Find more entities like US Patent 8790647 Treatment of vasculoproliferative conditions with Lrg1 anatgonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.